Medical Weight Loss 

Take back control of your overall health with a once-weekly injection

​

​via
 

starting at $349/month plus consultation fee​​​​​​​​​​​

 

   Zepbound® 2.5mg    $349/month 

  Zepbound® 5 mg       $499/month

    Zepbound® 7.5mg     $499/month* 

    Zepbound® 10mg      $499/month**

*Special offer pricing for 1st fill and refills made within 45 days of prior delivery. Regular price $599.

**Special offer pricing for 1st fill and refills made within 45 days of prior delivery. Regular price $699.

For more information on medication pricing visit https://lillydirect.lilly.com/pharmacy/zepbound

New Patient Initial Virtual Consultation $150
Monthly follow up $100/month
 

 

What to Expect
Zepbound® (tirzeptide) is an injectable medication to help you use weight in addition to healthy lifestyle modification.  Zepbound® helps to slow down your GI tract which helps you feel fuller for longer and reduce the signaling of your "hungry hormone" to your brain, helping you eat less to achieve a calorie deficit, ultimately producing weight loss.  

It is important to maintain adequate protein and water intake while on this medication. The most commonly reported side effects are nausea, early satiety, indigestion, and constipation. Most people can lose up to 15-20% of their total body weight with compounded peptides along with diet and exercise modification.

Clients should commit to a minimum of 2-3 months. Some people elect to use this medication for up to a year or more, depending on their BMI and weight loss goals. 

Program Eligibility Criteria

New patients:
Clinically overweight or seeking maintenance from a previous program
Ability/willingness to self-inject once weekly 
Access to technology for virtual exams/follow up
Not currently pregnant or breastfeeding
Access to a scale
Blood work available for review within the last year
Established with a primary care provider

​

Clients with diabetes or advanced comorbid conditions will be excluded and

referred back to their regular care providers for management

 

Applicants with personal or family history of Multiple Endocrine Neoplasia type 2

or medullary thyroid cancer will not be permitted

​